View Article

  • Implants For Cardiovascular Diseases

  • 1Student of Six Sigma Institute of Technology and Science
    2Principal of Six Sigma Institute of Technology and Science
    3Asst. Professor Six Sigma Institute of Technology and Science
     

Abstract

Cardiovascular diseases (CVDs) remain a leading cause of morbidity and mortality globally, necessitating continuous advancements in medical interventions. Implantable devices have emerged as promising solutions for managing various aspects of cardiovascular pathologies. This comprehensive review explores the current landscape of innovative implants in the realm of cardiovascular diseases. The review begins by examining the pivotal role of implantable devices in addressing cardiac conditions, ranging from heart failure to arrhythmias. Focus is placed on cardiac rhythm management devices, including pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy devices, highlighting their evolving technologies and clinical applications. Furthermore, the review delves into advancements in the field of cardiovascular stents, discussing novel materials and designs aimed at optimizing vascular patency while minimizing complications. The integration of drug-eluting technologies and bioresorbable materials into stent development is explored, with emphasis on their impact on patient outcomes. The discussion extends to ventricular assist devices (VADs) and total artificial hearts, elucidating their role in providing temporary or long-term mechanical circulatory support. A critical evaluation of challenges and future prospects in enhancing the biocompatibility and durability of these devices is presented. In addition, the review encompasses the burgeoning field of bioelectronic implants, elucidating how neuromodulation devices and bioelectronic medicine are revolutionizing the management of hypertension and heart failure. The integration of smart sensors and closed-loop systems for real-time monitoring and adaptive interventions is discussed in the context of personalized cardiovascular care. Ultimately, this review aims to provide a comprehensive overview of the diverse landscape of cardiovascular implants, offering sights into their evolving technologies, clinical efficacy, and potential avenues for future research and development.The continuous innovation in implantable devices holds great promise for improving the prognosis and quality of life for individuals affected by cardiovascular diseases.

Keywords

Cardiovascular disease, Implants

Reference

  1. Tetali, S., Fricker, A., Van Dom burg, Y., & Roy, I. (2023). Intelligent biomaterials for cardiovascular applications. Current Opinion in Biomedical Engineering, 28, 100474. https://doi.org/10.1016/j.cobme.2023.100474
  2. Qi, P., Maitz, M. F., & Huang, N. (2013). Surface modification of cardiovascular materials and implants. Surface and Coatings Technology, 233, 80–90. Doi: 10.1016/j.surfcoat.2013.02.00
  3. Adhami M, Martin NK, Maguire C, Courtenay AJ, Donnelly RF, Domínguez-Robles J, Larrañeta E. Drug loaded implantable devices to treat cardiovascular disease. Expert Opin Drug Deliv. 2023 Apr;20(4):507-522. Doi: 10.1080/17425247.2023.2190580.
  4. Nangia, R., Singh, H., & Kaur, K. (2016). Prevalence of cardiovascular disease (CVD) risk factors. Medical Journal Armed Forces India, 72(4), 315–319. Doi: 10.1016/j.mjafi.2014.07.007  
  5. Bussooa, A., Neale, S., & Mercer, J. (2018). Future of Smart Cardiovascular Implants. Sensors, 18(7), 2008. doi:10.3390/s18072008
  6. Jung, F., Wischke, C., & Lendlein, A. (2010). Degradable, Multifunctional Cardiovascular Implants: Challenges and Hurdles. MRS Bulletin, 35(08), 607–613. doi:10.1557/mrs2010.529 
  7. Levy, R. J., Johnston, T. P., Sintov, A., & Golomb, G. (1990). Controlled release implants for cardiovascular disease. Journal of Controlled Release, 11(1-3), 245–254. doi:10.1016/0168-3659(90)90137-i
  8. Wischke, C., & Lendlein, A. (2011). Designing multifunctional polymers for cardiovascular implants. Clinical Hemorheology and Microcirculation, 49(1-4), 347–355. doi:10.3233/ch-2011-1485 
  9. Stanis?awska, A... "Biomaterials and Implants in Cardiac and Vascular Surgery - Review" Advances in Materials Science, vol.14, no.3, 2014, pp.5-17. https://doi.org/10.2478/adms-2014-0010
  10. Hermawan, H., Dubé, D., & Mantovani, D. (2010). Degradable metallic biomaterials for cardiovascular applications. Metals for Biomedical Devices, 379–404. doi:10.1533/9781845699246.4.379
  11. Lei, L., Guo, S.-R., Chen, W.-L., Rong, H.-J., & Lu, F. (2011). Stents as a platform for drug delivery. Expert Opinion on Drug Delivery, 8(6), 813–831. doi:10.1517/17425247.2011.572068
  12. Mani, G. (2013). Stent-based drug-delivery systems: current challenges and future trends. Therapeutic Delivery, 4(9), 1079–1082. doi:10.4155/tde.13.63
  13. Merchant, Faisal M., G. William Dec, and Jagmeet P. Singh. "Implantable sensors for heart failure." Circulation: Arrhythmia and Electrophysiology 3, no. 6 (2010): 657-667.
  14. Implantable cardioverter-defibrillators (ICDs) - Mayo Clinic
  15. Implantable Cardioverter Defibrillator (ICD) - Dr Matthew Ginks (oxfordheartdoctor.com)
  16. Køber, L., Thune, J. J., Nielsen, J. C., Haarbo, J., Videbæk, L., Korup, E., … Pehrson, S. (2016). Defibrillator Implantation in Patients with Nonischaemic Systolic Heart Failure. New England Journal of Medicine, 375(13), 1221–1230. doi:10.1056/nejmoa1608029  
  17. A. Molloy et al., "Challenges to the Development of the Next Generation of Self-Reporting Cardiovascular Implantable Medical Devices," in IEEE Reviews in Biomedical Engineering, vol. 15, pp. 260-272, 2022, doi: 10.1109/RBME.2021.3110084
  18. Lee, Justin Z., Siva K. Mulpuru, and Win K. Shen. "Leadless pacemaker: performance and complications." Trends in Cardiovascular Medicine 28, no. 2 (2018): 130-141.
  19. Khan, K., Kim, J. A., Gurgu, A., Khawaja, M., Cozma, D., & Chelu, M. G. (2021). Innovations in Cardiac Implantable Electronic Devices. Cardiovascular Drugs and Therapy. doi:10.1007/s10557-021-07163-5 
  20. Sengel, Ceyda Tuba. "Delivery of nanoparticles for the treatment of cardiovascular diseases." Global Journal of Obesity, Diabetes and Metabolic Syndrome 2 (2015): 18-21.
  21. Abraham, William T., and Leor Perl. "Implantable hemodynamic monitoring for heart failure patients." Journal of the American College of Cardiology 70, no. 3 (2017): 389-398.

 

Photo
Komal Bisht
Corresponding author

Student of Six Sigma Institute of Technology and Science

Photo
Vijay Singh
Co-author

Principal of Six Sigma Institute of Technology and Science

Photo
Sushmita Bala
Co-author

Asst. Professor Six Sigma Institute of Technology and Science

Komal Bisht*, Vijay Singh, Sushmita Bala, Implants For Cardiovascular Diseases, Int. J. in Pharm. Sci., 2023, Vol 1, Issue 12, 650-658. https://doi.org/10.5281/zenodo.10428745

More related articles
Single-Cell Multi-Omics and Cell-Type-Specific Mol...
Anchal, Gaurav Hastir, Amar Pal Singh, Ajeet Pal Singh, Rajesh Ku...
Assessment of Chemotherapy-Induced Toxicities of F...
Dr.swathi Boddupally , Dornala Manoj, Jarupla Mahika, Mogilicharl...
Toxicological Evaluation of Capox Regimen in Color...
Dr. Swathi Boddupally, Dornala Manoj, Jarupla Mahika, Mogilicharl...
Ambispective Study of the Toxicological Profile of Cisplatin in Head and Neck Sq...
Dr. Swathi Boddupally, Jarupla Mahika, Dornala Manoj, Nermetla Mahesh, Oddi Sahithi, Mogilicharla Ar...
Navigating Cisplatin Toxicity in Cervical Cancer: Clinical Insights from a Case ...
Dr. Swathi Boddupally , Mogilicharla Archana, Dornala Manoj, Nermetla Mahesh, Oddi Sahithi, Jarupla ...
GoldenShield: A Petal-Powered Antioxidant Cream...
Dr. Ulka Aade, Nashra Bano, Sandhya Jaiswal, Priyanka Jha, Akisha Irfan Sayed, Ghanshyam Kedar...
Related Articles
Comparative Evaluation of Antimicrobial and Anti-inflammatory Activity of Jatrop...
Bhuvana Ezhil Rohini R, Vaishnavi B, Ragu Semaraj T, Kishore Kumar R, Janani R, Abinaya V, Sujatha ...
Formulation and Evaluation of Azelnidipine-Loaded Nanosponges for Enhanced Solub...
Kunal Wankhede, Yash Chaudhari, Shahid Nafees, Mobeen Manyar...
Preliminary Screening Of The Antisickling Properties Of Brillantaisia Owariensis...
Evans Edoghotu, Abdu Abdulrasheed, Torugbene Tamarabarakemi, Diepreye Ere...
Single-Cell Multi-Omics and Cell-Type-Specific Molecular Mechanisms in Parkinson...
Anchal, Gaurav Hastir, Amar Pal Singh, Ajeet Pal Singh, Rajesh Kumar...
More related articles
Single-Cell Multi-Omics and Cell-Type-Specific Molecular Mechanisms in Parkinson...
Anchal, Gaurav Hastir, Amar Pal Singh, Ajeet Pal Singh, Rajesh Kumar...
Assessment of Chemotherapy-Induced Toxicities of FOLFOX Regimen in Pancreatic Ca...
Dr.swathi Boddupally , Dornala Manoj, Jarupla Mahika, Mogilicharla Archana, Nermetla Mahesh, Oddi Sa...
Toxicological Evaluation of Capox Regimen in Colorectal Cancer Therapy...
Dr. Swathi Boddupally, Dornala Manoj, Jarupla Mahika, Mogilicharla Archana, Oddi Sahithi, Nermetla M...
Single-Cell Multi-Omics and Cell-Type-Specific Molecular Mechanisms in Parkinson...
Anchal, Gaurav Hastir, Amar Pal Singh, Ajeet Pal Singh, Rajesh Kumar...
Assessment of Chemotherapy-Induced Toxicities of FOLFOX Regimen in Pancreatic Ca...
Dr.swathi Boddupally , Dornala Manoj, Jarupla Mahika, Mogilicharla Archana, Nermetla Mahesh, Oddi Sa...
Toxicological Evaluation of Capox Regimen in Colorectal Cancer Therapy...
Dr. Swathi Boddupally, Dornala Manoj, Jarupla Mahika, Mogilicharla Archana, Oddi Sahithi, Nermetla M...